Free Offer
Open Demat FREE
Apply in Avience Biomedicals Ltd IPO via ASBA / UPI
₹0 Opening Digital KYC 1-Click Apply
SEBI Regulated · 100% Secure · Under 5 Min
Home All IPOs Avience Biomedicals Ltd IPO
Avience Biomedicals Ltd IPO
NSE SME Bookbuilding IPO Fresh capital only Closed Live Chart
GMP +₹75 +36.06% Est. Listing ₹283 P&L/Lot +₹45,000
Issue Price
₹208
Face ₹10
GMP
+₹75
+36.06% premium
Est. Listing
₹283
GMP based
Subscribed
267.95
🔥 Hot
Min Amount
₹124,800
1 lot · 600 shares
Live Price
tap to chart
Allotment
Important Dates
6/6 completed
Open
Close
Allotment
Refund
Demat
Listing
Done
Open Date
18 Jun 2026
Thu Completed
Done
Close Date
22 Jun 2026
Mon Completed
Done
Allotment
23 Jun 2026
Tue Completed
Done
Refund
24 Jun 2026
Wed Completed
Done
Demat Credit
24 Jun 2026
Wed Completed
Done
Listing Date
25 Jun 2026
Thu Completed
Issue Details
Pricing & Size
Issue Price
₹208 Face ₹10
Lot Size
600 shares
Min Investment
₹124,800
Total Issue Size
14,53,800 shares (agg. up to ₹30 Cr)
IPO Information
Issue Type
Bookbuilding IPO
Sale Type
Fresh capital only
Listing Exchange
NSE SME
Script / Ticker
-
Allocation Breakdown
Market Maker
82,200
QIB Portion
683400.00
NII / HNI
207000.00
Retail
481200.00
Employee
-
Net Offer to Public
13,71,600 shares (agg. up to ₹29 Cr)
Shareholding Pattern
Pre-Issue Shareholding
40,31,256 shares
Post-Issue Shareholding
54,85,056 shares
Application Size
CategoryMin LotsSharesAmount
Retail (sNII) 2 1,200 ₹2,49,600
HNI / NII 3 1,800 ₹3,74,400
Objects of Issue
3 objectives
1
Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh
15.96 Cr
2
Funding the working capital requirements of the Company
8.25 Cr
3
General Corporate Purposes
Lead Managers & Market Maker
Book Running Lead Managers
Fintellectual Corporate Advisors Pvt.Ltd
Market Maker
Asnani Stock Broker Pvt.Ltd
IPO Timeline
Open
18 Jun
✓ Done
Close
22 Jun
✓ Done
Allotment
23 Jun
✓ Done
Listing
25 Jun
✓ Done
Registrar Details
Skyline Financial Services Pvt.Ltd
SEBI Registered Registrar & Transfer Agent
Phone
02228511022
Email
ipo@skylinerta.com
Company Contact
Email
info@avienbio.com
Phone
1800-12-04-636
Address
C-11, Block-C Community Centre, Janakpuri A-3, Delhi, New Delhi, 110058
Grey Market Premium
LIVE
Current GMP
+₹75
+36.06% vs Issue Price
Issue Price
₹208
Est. Listing
₹283
Lot Size
600 shares
P&L / Lot
+₹45,000
GMP is unofficial grey market data. Does not guarantee listing price or returns.
GMP Return Calculator
Estimated Listing
GMP %
Investment (1 Lot)
Total Investment
Expected P&L
ROI
Avience Biomedicals Ltd LIVE
INR ·
vs Issue
Open
High
Low
Mkt Cap
P/E
52W H
52W L
Vol
Div
Yld
Loading chart…
Live Chart Not Available
Avience Biomedicals Ltd is not yet listed or data is unavailable.
Chart will appear after listing
| Price
Market Reference
IPO Issue Price
₹208
GMP
+₹75 (+36.06%)
GMP Est. Listing
₹283
Previous Close
Exchange
Data from Yahoo Finance. May be delayed 15–20 min. GMP is unofficial. Not investment advice.
267.95
Overall Sub.
🔥 Hot
78.80
QIB
394.72
Retail
Category-wise Subscription
Category Sub (×) Offered Bid For Amt (Cr)*
QIB 78.80× 6,83,400 5,38,52,200 ₹1,120.13 Cr
NII / HNI (Total) 597.72× 2,07,000 12,37,27,200 ₹2,573.53 Cr
Retail Investors 394.72× 4,81,200 18,99,40,800 ₹3,950.77 Cr
Total ** 267.95× 13,71,600 36,75,20,200 ₹7,644.42 Cr
Market Maker * 82,200 82,200 ₹1.71 Cr
* Based on ₹208.00 (upper price band)
NII / HNI Breakdown
Shares Reserved
QIB
6,83,400
NII
2,07,000
Retail
4,81,200
Market Maker
82,200
* Shares Offered and Total Amount are indicative. ** Excluding Market Maker portion. Data sourced from exchange bidding platform.
Financial Summary
Amount in ₹ Crore
Metric31 Mar 202531 Mar 202431 Mar 2023
Revenue29.5416.6410.93
PAT5.191.990.78
EBITDA7.653.151.43
Net Worth20.606.074.08
Total Assets43.6025.6310.02
Reserves16.572.790.79
Borrowings13.757.732.66
Key Financial Ratios
22.38
ROE
Return on Equity
16.99
ROCE
Return on Capital Employed
22.38
RONW
Return on Net Worth
15.86
PAT Margin
PAT / Revenue
24.70
EBITDA Mgn
EBITDA / Revenue
0.94
D/E Ratio
Debt to Equity
2.94
P/BV
Price to Book Value
17.94
Pre EPS
EPS Pre-Issue
12.56
Post EPS
EPS Post-Issue
11.59
Pre P/E
P/E Pre-Issue
16.56
Post P/E
P/E Post-Issue
About Avience Biomedicals Ltd

Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry.

Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets.

The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas.

In addition to manufacturing, the Company also act as distributors and traders of medical equipment.

The company's manufacturing unit is situated in Noida, Uttar Pradesh.

The company offers a comprehensive range of diagnostic solutions, including:

  • Rapid Test Kits: Products like AVISURE Dengue Combo Test, Malaria Rapid Test (Pf/Pv), and AVISURE Syphilis Rapid Test.
  • Biochemistry Analyzers and Reagents: Devices like the BS-240 Fully Auto Analyzer and reagents like AVIENBIO Albumin Kit.
  • Molecular Diagnostics: COVID-19 detection kits, including the COVID-19 Hid RTqPCR ASSAY.
  • Hematology Analyzers: Models like the BC-20s 3-Part Hematology Analyzer.
  • Medical Devices: Oxygen concentrators (Oxy-5 and Oxy-10) and viral transport solutions (VTM).

As of January 31, 2026, the company had 75 permanent employees and 33 contractual employees

Competitive Strength

  • Strong Industry Experience and Expertise.
  • Avience provides various diagnostic products, including rapid test kits, analyzers, hematology devices, and molecular kits.
  • Strong distribution network across India and is growing its international footprint.
  • Cost-Effective and Affordable Solutions.
  • Stringent quality control processes and complies with ISO standards and regulatory approvals.
Frequently Asked Questions
What is the issue price of Avience Biomedicals Ltd IPO?
The issue price of Avience Biomedicals Ltd IPO is ₹208 per share, face value ₹10.
What is the lot size?
Minimum lot size is 600 shares, requiring ₹124,800.
What are the IPO dates?
Opens 18 Jun 2026, closes 22 Jun 2026.
When is the listing date?
Tentative listing: 25 Jun 2026 on NSE SME.
What is the current GMP?
Current GMP is +₹75, estimated listing ₹283 (+36.06%). GMP is unofficial.
How to apply?
Apply via ASBA through your bank, or via UPI through any broker app.

Check Allotment Status

Avience Biomedicals Ltd IPO · Expected 23 Jun 2026

Check on Registrar
Post-IPO Timeline
Allotment Date
23 Jun 2026
Refund Initiation
24 Jun 2026
Demat Credit
24 Jun 2026
Listing Date
25 Jun 2026
Live Price LIVE
Quick Facts
Closed
GMP Signal
Bullish
+₹75
+36.06%
Issue Price
₹208
Face ₹10
Lot Size
600
shares / lot
Min Amount
₹124,800
1 lot
Est. Listing
₹283
GMP +₹75
Subscription
Overall267.95×
QIB78.80×
NII597.72×
Retail394.72×
Key Dates
Open
18 Jun Done
Close
22 Jun Done
Listing
25 Jun Done
Registrar
Skyline Financial Services Pvt.Ltd
A
Sponsored
₹0 AMC · Apply IPOs via UPI
SEBI Regulated · Digital KYC in 5 min